In summary, p16 overexpression is a constant, but not an exclusive finding in esophageal small-cell carcinomas and could be detected in poorly differentiated and basaloid squamous cell carcinomas albeit with less frequency. This evidence concerns the gene CDKN2A and esophageal small cell neuroendocrine carcinoma.